ENG

STARCCLAB

Development of inhalation-enhanced new drugs and non-clinical CRO services using advanced/animal replacement tests
Representative
Young-Jae Cho / Division of Pulmonary and Critical Care Medicine
Associated Disease
ARDS, respiratory infections (viruses, non-tuberculous mycobacteria), inhalation injury
Requirements
Investment , Business model consult, joint research , M&A
Views
0

ARPI Inc.

ECG BuddyECG Buddy
Representative
Joonghee Kim /
Requirements
Investment
Views
439

DCGEN

Representative
Han /
Requirements
Investment
Views
186

Related Sites